Literature DB >> 21321478

Ivermectin, 'wonder drug' from Japan: the human use perspective.

Andy Crump1, Satoshi Ōmura.   

Abstract

Discovered in the late-1970s, the pioneering drug ivermectin, a dihydro derivative of avermectin--originating solely from a single microorganism isolated at the Kitasato Institute, Tokyo, Japan from Japanese soil--has had an immeasurably beneficial impact in improving the lives and welfare of billions of people throughout the world. Originally introduced as a veterinary drug, it kills a wide range of internal and external parasites in commercial livestock and companion animals. It was quickly discovered to be ideal in combating two of the world's most devastating and disfiguring diseases which have plagued the world's poor throughout the tropics for centuries. It is now being used free-of-charge as the sole tool in campaigns to eliminate both diseases globally. It has also been used to successfully overcome several other human diseases and new uses for it are continually being found. This paper looks in depth at the events surrounding ivermectin's passage from being a huge success in Animal Health into its widespread use in humans, a development which has led many to describe it as a "wonder" drug.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21321478      PMCID: PMC3043740          DOI: 10.2183/pjab.87.13

Source DB:  PubMed          Journal:  Proc Jpn Acad Ser B Phys Biol Sci        ISSN: 0386-2208            Impact factor:   3.493


  48 in total

1.  Mass treatment with ivermectin: an underutilized public health strategy.

Authors:  Rick Speare; David Durrheim
Journal:  Bull World Health Organ       Date:  2004-09-13       Impact factor: 9.408

2.  Migration and death of skin-dwelling Onchocerca volvulus microfilariae after treatment with ivermectin.

Authors:  B O Duke; G Soula; G Zea-Flores; G L Bratthauer; O Doumbo
Journal:  Trop Med Parasitol       Date:  1991-03

3.  Onchocerciasis and its control. Report of a WHO Expert Committee on Onchocerciasis Control.

Authors: 
Journal:  World Health Organ Tech Rep Ser       Date:  1995

4.  Avermectins, new family of potent anthelmintic agents: isolation and chromatographic properties.

Authors:  T W Miller; L Chaiet; D J Cole; L J Cole; J E Flor; R T Goegelman; V P Gullo; H Joshua; A J Kempf; W R Krellwitz; R L Monaghan; R E Ormond; K E Wilson; G Albers-Schönberg; I Putter
Journal:  Antimicrob Agents Chemother       Date:  1979-03       Impact factor: 5.191

5.  Efficacy and tolerance of ivermectin in human onchocerciasis.

Authors:  M A Aziz; S Diallo; I M Diop; M Lariviere; M Porta
Journal:  Lancet       Date:  1982-07-24       Impact factor: 79.321

6.  Ivermectin, a new broad-spectrum antiparasitic agent.

Authors:  J C Chabala; H Mrozik; R L Tolman; P Eskola; A Lusi; L H Peterson; M F Woods; M H Fisher; W C Campbell; J R Egerton; D A Ostlind
Journal:  J Med Chem       Date:  1980-10       Impact factor: 7.446

7.  Impact of mass treatment of onchocerciasis with ivermectin on the transmission of infection.

Authors:  H R Taylor; M Pacqué; B Muñoz; B M Greene
Journal:  Science       Date:  1990-10-05       Impact factor: 47.728

8.  Double-blind study of ivermectin and diethylcarbamazine in African onchocerciasis patients with ocular involvement.

Authors:  M Lariviere; P Vingtain; M Aziz; B Beauvais; D Weimann; F Derouin; J Ginoux; H Schulz-Key; P Gaxotte; D Basset
Journal:  Lancet       Date:  1985-07-27       Impact factor: 79.321

Review 9.  Ivermectin in human medicine.

Authors:  E A Ottesen; W C Campbell
Journal:  J Antimicrob Chemother       Date:  1994-08       Impact factor: 5.790

10.  Impact of long-term treatment with ivermectin on the prevalence and intensity of soil-transmitted helminth infections.

Authors:  Ana Lucia Moncayo; Maritza Vaca; Leila Amorim; Alejandro Rodriguez; Silvia Erazo; Gisela Oviedo; Isabel Quinzo; Margarita Padilla; Martha Chico; Raquel Lovato; Eduardo Gomez; Mauricio L Barreto; Philip J Cooper
Journal:  PLoS Negl Trop Dis       Date:  2008-09-10
View more
  70 in total

1.  Subunit stoichiometry and arrangement in a heteromeric glutamate-gated chloride channel.

Authors:  Nurit Degani-Katzav; Revital Gortler; Lilach Gorodetzki; Yoav Paas
Journal:  Proc Natl Acad Sci U S A       Date:  2016-01-20       Impact factor: 11.205

2.  Ivermectin Impairs the Development of Sexual and Asexual Stages of Plasmodium falciparum In Vitro.

Authors:  Lais Pessanha de Carvalho; Thaisa Lucas Sandri; Edésio José Tenório de Melo; Rolf Fendel; Peter G Kremsner; Benjamin Mordmüller; Jana Held
Journal:  Antimicrob Agents Chemother       Date:  2019-07-25       Impact factor: 5.191

3.  Avermectins differentially affect ethanol intake and receptor function: implications for developing new therapeutics for alcohol use disorders.

Authors:  Liana Asatryan; Megan M Yardley; Sheraz Khoja; James R Trudell; Nhat Hyunh; Stan G Louie; Nicos A Petasis; Ronald L Alkana; Daryl L Davies
Journal:  Int J Neuropsychopharmacol       Date:  2014-01-22       Impact factor: 5.176

Review 4.  Hit and lead criteria in drug discovery for infectious diseases of the developing world.

Authors:  Kei Katsuno; Jeremy N Burrows; Ken Duncan; Rob Hooft van Huijsduijnen; Takushi Kaneko; Kiyoshi Kita; Charles E Mowbray; Dennis Schmatz; Peter Warner; B T Slingsby
Journal:  Nat Rev Drug Discov       Date:  2015-10-05       Impact factor: 84.694

5.  Macrophage P2X4 receptors augment bacterial killing and protect against sepsis.

Authors:  Balázs Csóka; Zoltán H Németh; Ildikó Szabó; Daryl L Davies; Zoltán V Varga; János Pálóczi; Simonetta Falzoni; Francesco Di Virgilio; Rieko Muramatsu; Toshihide Yamashita; Pál Pacher; György Haskó
Journal:  JCI Insight       Date:  2018-06-07

Review 6.  Preclinical evaluation of avermectins as novel therapeutic agents for alcohol use disorders.

Authors:  Sheraz Khoja; Nhat Huynh; Alicia M P Warnecke; Liana Asatryan; Michael W Jakowec; Daryl L Davies
Journal:  Psychopharmacology (Berl)       Date:  2018-03-02       Impact factor: 4.530

Review 7.  A Scoping Insight on Potential Prophylactics, Vaccines and Therapeutic Weaponry for the Ongoing Novel Coronavirus (COVID-19) Pandemic- A Comprehensive Review.

Authors:  Priyanka Dash; Subhashree Mohapatra; Sayantan Ghosh; Bismita Nayak
Journal:  Front Pharmacol       Date:  2021-02-26       Impact factor: 5.810

8.  Multiday administration of ivermectin is effective in reducing alcohol intake in mice at doses shown to be safe in humans.

Authors:  Megan M Yardley; Michael Neely; Nhat Huynh; Liana Asatryan; Stan G Louie; Ronald L Alkana; Daryl L Davies
Journal:  Neuroreport       Date:  2014-09-10       Impact factor: 1.837

9.  Insights into the impact of Ivermectin on some protein aspects linked to Culex pipiens digestion and immunity.

Authors:  Magda Said A Abdeltawab; S A Rifaie; E Y Shoeib; H A Abd El-Latif; M Badawi; W H Salama; A A Abd El-Aal
Journal:  Parasitol Res       Date:  2019-11-30       Impact factor: 2.289

10.  A BRIEF REVIEW ON THE MODE OF ACTION OF ANTINEMATODAL DRUGS.

Authors:  Melanie Abongwa; Richard J Martin; Alan P Robertson
Journal:  Acta Vet (Beogr)       Date:  2017-06-26       Impact factor: 0.800

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.